Molecular Imaging Market: By Device Type Scanner, Single Photon Emission Computed Tomography Scanner, Gamma Camera, Nuclear Magnetic Resonance Spectrometer, Magnetic Resonance Spectroscopy, Optical Imaging, Molecular Ultrasound Imaging, Others), By Application, By End-user and Region Forecast 2020-2031
Molecular Imaging Market size was valued at US$ 4,668.7 million in 2024 and is expected to reach US$ 6,791.4 million by 2031, growing at a significant CAGR of 5.5% from 2025-2031. The global market provides a detailed overview of the market that can be segmented by device type, application, and end user. By device type, the market has been segmented into Positron Emission Tomography (PET) Scanners, Single Photon Emission Computed Tomography (SPECT) Scanner, Gamma Cameras, Nuclear Magnetic Resonance (NMR) Spectrometers, Magnetic Resonance Spectroscopy, Optical Imaging, Molecular Ultrasound Imaging and Others.
The Positron Emission Tomography (PET) Scanner segment is likely to be the largest and fastest-growing segment in terms of device type. Based on application, the market is segmented into cardiovascular, neurology, respiratory, oncology, gastrointestinal disorders, and others. Among these, the cardiovascular segment is expected to have the fastest-growing market during the forecast period. Based on end users, the market is segregated into hospitals, ambulatory surgical centers, diagnostic imaging centers, and others. The hospitals held a considerable market share during the forecast period.
Study Period
2025-2031Base Year
2024CAGR
5.5%Largest Market
North-AmericaFastest Growing Market
North-America
Rising demand for accurate and reliable imaging systems for more accurate and detailed disease diagnosis, rising frequency of numerous chronic diseases, and ongoing development and innovation in molecular imaging technologies are some key factors fostering the market growth.
Asia Pacific market is expected to witness the highest market share during the forecast period. The prevalence of chronic diseases, urbanization, the aging population, and the need for better diagnostic treatment are all likely to contribute to the region's growth. North America held a considerable market share during the estimated period due to a surge in healthcare funding from public and commercial organizations for the creation of technologically sophisticated medical systems to meet the demands of a growing population suffering from various ailments
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2025-2031 |
|
Market Size in 2024 |
US$ 4,668.7 million |
|
Market Size in 2031 |
US$ 6,791.4 million |
|
Market CAGR |
5.5% |
|
By Device Type |
|
|
By Application |
|
|
By End User |
|
|
By Region |
|
Download Free Sample Report
The molecular imaging market size was valued at US$ 4,668.7 million in 2024 and is expected to reach US$ 6,791.4 million by 2031, growing at a significant CAGR of 5.5% from 2025-2031
The market key players are: Hitachi Medical Corporation (Japan) Siemens Healthineers (Germany) Toshiba Medical Systems (Japan) GE Healthcare (UK) Philips Healthcare (Netherlands) Esaote SpA (Italy) Sanrad Medical Systems Pvt. Ltd (India) Aurora Imaging Technology, Inc. (U.S.) SUMEC Group Corporation (China) Positron Corporation (U.S.)
The market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
| 1.Executive Summary |
| 2.Global Molecular Imaging Market Introduction |
| 2.1.Global Molecular Imaging Market - Taxonomy |
| 2.2.Global Molecular Imaging Market - Definitions |
| 2.2.1.Device Type |
| 2.2.2.Application |
| 2.2.3.End User |
| 2.2.4.Region |
| 3.Global Molecular Imaging Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Molecular Imaging Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
| 4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Molecular Imaging Market By Device Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 5.1. Positron Emission Tomography (PET) Scanner, |
| 5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Single Photon Emission Computed Tomography (SPECT) Scanner, |
| 5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Gamma Camera, |
| 5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Nuclear Magnetic Resonance (NMR) Spectrometer, |
| 5.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Magnetic Resonance Spectroscopy, |
| 5.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Optical Imaging, |
| 5.6.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 5.7. Molecular Ultrasound Imaging, |
| 5.7.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.7.3. Market Opportunity Analysis |
| 5.8. Others |
| 5.8.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.8.3. Market Opportunity Analysis |
| 6.Global Molecular Imaging Market By Application, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 6.1. Cardiovascular, |
| 6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Neurology, |
| 6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Respiratory, |
| 6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Oncology, |
| 6.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Gastrointestinal Disorder, |
| 6.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. Others |
| 6.6.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 7.Global Molecular Imaging Market By End User, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 7.1. Hospitals, |
| 7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Ambulatory Surgical Centers, |
| 7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Diagnostic Imaging Centers, |
| 7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Others |
| 7.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8.Global Molecular Imaging Market By Region, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Molecular Imaging Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 9.1. Device Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Positron Emission Tomography (PET) Scanner, |
| 9.1.2.Single Photon Emission Computed Tomography (SPECT) Scanner, |
| 9.1.3.Gamma Camera, |
| 9.1.4.Nuclear Magnetic Resonance (NMR) Spectrometer, |
| 9.1.5.Magnetic Resonance Spectroscopy, |
| 9.1.6.Optical Imaging, |
| 9.1.7.Molecular Ultrasound Imaging, |
| 9.1.8.Others |
| 9.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Cardiovascular, |
| 9.2.2.Neurology, |
| 9.2.3.Respiratory, |
| 9.2.4.Oncology, |
| 9.2.5.Gastrointestinal Disorder, |
| 9.2.6.Others |
| 9.3. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Hospitals, |
| 9.3.2.Ambulatory Surgical Centers, |
| 9.3.3.Diagnostic Imaging Centers, |
| 9.3.4.Others |
| 9.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Molecular Imaging Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 10.1. Device Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Positron Emission Tomography (PET) Scanner, |
| 10.1.2.Single Photon Emission Computed Tomography (SPECT) Scanner, |
| 10.1.3.Gamma Camera, |
| 10.1.4.Nuclear Magnetic Resonance (NMR) Spectrometer, |
| 10.1.5.Magnetic Resonance Spectroscopy, |
| 10.1.6.Optical Imaging, |
| 10.1.7.Molecular Ultrasound Imaging, |
| 10.1.8.Others |
| 10.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Cardiovascular, |
| 10.2.2.Neurology, |
| 10.2.3.Respiratory, |
| 10.2.4.Oncology, |
| 10.2.5.Gastrointestinal Disorder, |
| 10.2.6.Others |
| 10.3. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospitals, |
| 10.3.2.Ambulatory Surgical Centers, |
| 10.3.3.Diagnostic Imaging Centers, |
| 10.3.4.Others |
| 10.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 11.Asia Pacific (APAC) Molecular Imaging Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 11.1. Device Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Positron Emission Tomography (PET) Scanner, |
| 11.1.2.Single Photon Emission Computed Tomography (SPECT) Scanner, |
| 11.1.3.Gamma Camera, |
| 11.1.4.Nuclear Magnetic Resonance (NMR) Spectrometer, |
| 11.1.5.Magnetic Resonance Spectroscopy, |
| 11.1.6.Optical Imaging, |
| 11.1.7.Molecular Ultrasound Imaging, |
| 11.1.8.Others |
| 11.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Cardiovascular, |
| 11.2.2.Neurology, |
| 11.2.3.Respiratory, |
| 11.2.4.Oncology, |
| 11.2.5.Gastrointestinal Disorder, |
| 11.2.6.Others |
| 11.3. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospitals, |
| 11.3.2.Ambulatory Surgical Centers, |
| 11.3.3.Diagnostic Imaging Centers, |
| 11.3.4.Others |
| 11.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Molecular Imaging Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 12.1. Device Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Positron Emission Tomography (PET) Scanner, |
| 12.1.2.Single Photon Emission Computed Tomography (SPECT) Scanner, |
| 12.1.3.Gamma Camera, |
| 12.1.4.Nuclear Magnetic Resonance (NMR) Spectrometer, |
| 12.1.5.Magnetic Resonance Spectroscopy, |
| 12.1.6.Optical Imaging, |
| 12.1.7.Molecular Ultrasound Imaging, |
| 12.1.8.Others |
| 12.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Cardiovascular, |
| 12.2.2.Neurology, |
| 12.2.3.Respiratory, |
| 12.2.4.Oncology, |
| 12.2.5.Gastrointestinal Disorder, |
| 12.2.6.Others |
| 12.3. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospitals, |
| 12.3.2.Ambulatory Surgical Centers, |
| 12.3.3.Diagnostic Imaging Centers, |
| 12.3.4.Others |
| 12.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Molecular Imaging Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 13.1. Device Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Positron Emission Tomography (PET) Scanner, |
| 13.1.2.Single Photon Emission Computed Tomography (SPECT) Scanner, |
| 13.1.3.Gamma Camera, |
| 13.1.4.Nuclear Magnetic Resonance (NMR) Spectrometer, |
| 13.1.5.Magnetic Resonance Spectroscopy, |
| 13.1.6.Optical Imaging, |
| 13.1.7.Molecular Ultrasound Imaging, |
| 13.1.8.Others |
| 13.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Cardiovascular, |
| 13.2.2.Neurology, |
| 13.2.3.Respiratory, |
| 13.2.4.Oncology, |
| 13.2.5.Gastrointestinal Disorder, |
| 13.2.6.Others |
| 13.3. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospitals, |
| 13.3.2.Ambulatory Surgical Centers, |
| 13.3.3.Diagnostic Imaging Centers, |
| 13.3.4.Others |
| 13.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Hitachi Medical Corporation (Japan) |
| 14.2.2.Siemens Healthineers (Germany) |
| 14.2.3.Toshiba Medical Systems (Japan) |
| 14.2.4.GE Healthcare (UK) |
| 14.2.5.Philips Healthcare (Netherlands) |
| 14.2.6.Esaote SpA (Italy) |
| 14.2.7.Sanrad Medical Systems Pvt. Ltd (India) |
| 14.2.8.Aurora Imaging Technology, Inc. (U.S.) |
| 14.2.9.SUMEC Group Corporation (China) |
| 14.2.10.Positron Corporation (U.S.) |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Sample
